Masimo (NASDAQ:MASI) Earns “Buy” Rating from BTIG Research

Masimo (NASDAQ:MASI)‘s stock had its “buy” rating reiterated by stock analysts at BTIG Research in a report issued on Monday,Benzinga reports. They presently have a $198.00 price target on the medical equipment provider’s stock. BTIG Research’s price target suggests a potential upside of 35.16% from the company’s current price.

A number of other research firms have also recently issued reports on MASI. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. Zacks Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Wells Fargo & Company dropped their target price on shares of Masimo from $190.00 to $187.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Bank of America started coverage on Masimo in a research report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price target on the stock. Finally, Piper Sandler lifted their price objective on Masimo from $200.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Masimo presently has a consensus rating of “Hold” and a consensus price target of $188.40.

Masimo Stock Up 0.6%

MASI opened at $146.49 on Monday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.14 and a quick ratio of 1.61. The firm’s fifty day moving average price is $145.66 and its two-hundred day moving average price is $152.64. Masimo has a fifty-two week low of $133.70 and a fifty-two week high of $194.88. The company has a market capitalization of $7.87 billion, a P/E ratio of -17.19 and a beta of 1.28.

Masimo (NASDAQ:MASI) last posted its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share for the quarter. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The business had revenue of $617.00 million for the quarter. On average, analysts anticipate that Masimo will post 4.1 EPS for the current year.

Hedge Funds Weigh In On Masimo

A number of large investors have recently added to or reduced their stakes in the company. Choreo LLC bought a new position in shares of Masimo during the 1st quarter worth approximately $239,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Masimo in the first quarter worth $1,067,000. Assetmark Inc. boosted its holdings in Masimo by 25.7% during the first quarter. Assetmark Inc. now owns 1,466 shares of the medical equipment provider’s stock worth $244,000 after purchasing an additional 300 shares during the last quarter. TD Asset Management Inc boosted its holdings in Masimo by 4.8% during the first quarter. TD Asset Management Inc now owns 88,668 shares of the medical equipment provider’s stock worth $14,772,000 after purchasing an additional 4,028 shares during the last quarter. Finally, Picton Mahoney Asset Management grew its position in Masimo by 3.6% in the first quarter. Picton Mahoney Asset Management now owns 44,152 shares of the medical equipment provider’s stock valued at $7,355,000 after purchasing an additional 1,542 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.